Gossamer Bio (GOSS) Assets Average (2019 - 2026)

Gossamer Bio has reported Assets Average for 8 years, with the latest figure at $102.9 million in Q2 2026.

• On a quarterly basis, Assets Average fell 60.54% year-over-year to $102.9 million in Q2 2026; TTM through Jun 2026 was $102.9 million, a 60.54% decrease from a year earlier, with the FY2025 full-year figure at $243.8 million, down 22.27% from the prior year.
• Assets Average was $102.9 million for Q2 2026 at Gossamer Bio, down from $150.6 million in the prior quarter.
• The five-year high for Assets Average was $362.2 million in Q3 2024, with the low at $102.9 million in Q2 2026.
• Average Assets Average over 5 years is $263.3 million, with a median of $277.5 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Assets Average jumped 57.55% in 2024, then slumped 60.54% in 2026.
• Over 5 years, Assets Average stood at $298.0 million in 2022, then increased by 10.71% to $329.9 million in 2023, then climbed by 0.96% to $333.1 million in 2024, then sank by 42.8% to $190.5 million in 2025, then slumped by 46.0% to $102.9 million in 2026.
• The last three Assets Average figures came in at $102.9 million (Q2 2026), $150.6 million (Q1 2026), and $190.5 million (Q4 2025), per Business Quant data.